Head of Finance Geleen

Head of Finance

Geleen

• Enable Geleen site Operations (both CGT and mRNA TP) to achieve short‑and‑long‑term targets by providing insightful analysis and recommendations across all financial aspects of the plant, including cost transparency, product profitability, key performance indicators in production, innovation, cost savings, planning cycles, and net working capital.
• Manage monthly financial closing, forecast, and risk and opportunity processes in collaboration with BU Ops Controlling, GBSO, and Corporate FP&A.
• Co‑lead the 5‑year strategic planning process (BSR) for the Geleen site, focusing on sales, cost savings, productivity improvements, workforce evolution, innovation, investment planning, and inventory planning.
• Lead the annual budgeting process with the Site Leadership Team to meet corporate targets and deadlines.
• Conduct return‑on‑investment analysis for various CAPEX projects.
• Oversee process and system improvement projects (SAP enhancements, Nexus, new processes and tools, including AI‑based introductions) in partnership with local and global supply‑chain groups, corporate accounting, global operations, and sales departments.

• Proven planning and financial reporting experience.
• Strong business‑partnering skills and ability to collaborate effectively with multiple stakeholder management groups.
• Track record of influencing decision‑makers through data‑driven recommendations.
• Problem‑solving mindset with a results‑oriented approach.
• Experience in manufacturing finance.

• Expected gross salary in the Netherlands between €86,250 and €120,750, including an 8% holiday allowance.
• Opportunities for growth across multiple QC disciplines with hands‑on experience in a wide range of assays, GMP processes, and a supportive team environment that offers training, coaching, and clear development pathways.
• Direct contribution to the quality and safety of life‑changing therapies.